Temsirolimus is designed to slow the growth of kidney cancer cells by inhibiting several mechanisms that the cell uses to grow and survive. This should be considered during the preparation and administration of torisel, including storage time elapsed when in direct contact with pvc following constitution. It is usually given once a week over 30 to 60 minutes or as directed by your. Torisel temsirolimus is an intravenous inhibitor of mammalian target of rapamycin mtor, an intracellular protein that has been implicated in multiple growth related cellular functions. Temsirolimus is a powerful inhibitor of platelet activation and. Torisel is contraindicated in patients with bilirubin 1. Any relevant documentation to support medical necessity package insert, chart or lab notes, letter of medical necessity consult with the payer regarding specific claim and documentation requirements. Link to the pdf file there and select the pdf file, then ok. Inhibition of mtor activity resulted in a g1 growth arrest in treated tumor cells. Temsirolimus injection is used to treat advanced kidney cancer. Temsirolimus is considered experimental and investigational for all other indications.
This makes the pdf file part of the presentation file. Temsirolimus torisel, cci779 is a mammalian target of rapamycin mtor signal transduction inhibitor, which blocks a number of signal transduction pathways involved in cell cycle regulation. Torisel temsirolimus injection worldwide fact sheet. Torisel temsirolimus how suppliedstorage and handling. Temsirolimus treatment for 2 weeks also delays the growth of rapamycinresistant u251. Each kit is supplied in a single carton containing one singleuse vial of 25 mgml of temsirolimus and one diluent vial which includes a deliverable volume of 1. The torisel temsirolimus vial contains an overfill of 0. Temsirolimus is used to treat cancer of the kidneys, also called renal. Temsirolimus sensitive stimulation of platelet activity, apoptosis. Torisel kit te msirolimus injection, for intr avenous infusion only.
Inhibitors of cyp3a4 and pgp increase sirolimus concentrations. It blocks the effects of a protein called mtor that is often over active in cancer cells. Clinical trials using temsirolimus national cancer institute. Mar 23, 2010 temsirolimus is a prodrug of sirolimus, which is marketed as rapamune wyeth pharmaceuticals, inc. Temsirolimus in treating patients with metastatic neuroendocrine carcinoma the safety and scientific validity of this study is the responsibility of the study sponsor and. Temsirolimus torisel temsirolimus torisel is a chemotherapy regimen for renal cell carcinoma kidney cancer.
Highlights of prescribing information these highlights. Temsirolimus is used to treat cancer of the kidneys, also called renal cell carcinoma. Please see full prescribing information for torisel temsirolimus. Temsirolimus is a substrate of the efflux transporter pglycoprotein pgp in vitro. Treatment with the mtor inhibitor temsirolimus partially diminished survivin levels and this effect was augmented by the addition. Definition from the nci drug dictionary detailed scientific definition and other names for this drug. Patients enrolled in the study had advanced disease and three or more factors indicating a. Prescribing information hycamtin topotecan hydrochloride for injection for intravenous use warning hycamtin topotecan hydrochloride for injection should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. Temsirolimus comes as a solution liquid to be given by infusion slow injection into a vein over 30 to 60 minutes. Temsirolimus also stops the cancer from making blood vessels, which the cells need to be able to grow. Temsirolimus is used in the treatment of advanced renal cell. Temsirolimus is a type of targeted cancer drug treatment called an mtor inhibitor. Follow applicable special handling and disposal procedures 1.
Open the powerpoint slide where you want to insert the pdf. A phase 2 study with a daily regimen of the oral mtor. Temsirolimus is the 2,2bis hydroxymethyl propionic acid ester of sirolimus, a macrocyclic lactone produced by streptomyces hygroscopicus. Hospital outpatient medicare only hospital outpatient facilities may use ccodes to report drugs and procedures provided to medicare patients. Temsirolimus is a targeted therapy and is classified as a mtor inhibitor. Temsirolimus infusion should be interrupted in all patients with severe infusion reactions and appropriate medical therapy administered.
Temsirolimus binds to and inhibits the mammalian target of rapamycin mtor, resulting in decreased expression of mrnas necessary for cell cycle progression and arresting cells in the g1 phase of the cell cycle. Temsirolimus, interferon alfa, or both for advanced renalcell carcinoma. Torisel temsirolimus torisel 25 mg concentrate for injection. Torisel temsirolimus is indicated for the treatment of advanced renal cell carcinoma. Phase iii study to evaluate temsirolimus compared with investigators choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. Renal cell carcinoma treatment regimens cancer therapy advisor. In powerpoint, select the slide that you want to add the file to, and then select insert object. Temsirolimus is an inhibitor of mtor mammalian target of rapamycin. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Due to the intentional overfill in the torisel injection vial, the drug concentration of the resulting solution. Etopophos etoposide phosphate for injection is an antineoplastic agent which is available for intravenous infusion as a sterile lyophile in singledose vials containing etoposide phosphate. Sirolimus is extensively metabolized in the intestinal wall and liver and undergoes countertransport from enterocytes of the small intestine into the gut lumen.
Potential histologic and molecular predictors of response to. Temsirolimus side effects, dosage, interactions drugs. The concentratediluent mixture is stable below 25c for up to 24 hours. All trials on the list are supported by nci ncis basic information about clinical. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your face or throat or a severe skin reaction fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling. This medication is given by injection into a vein by a health care professional. Excreted in feces 78% and urine 5% following iv dosing within 14 days.
Apr 05, 2018 what are the possible side effects of temsirolimus torisel. To report an adverse event, please call 18004381985. The study reported that median overall survival was longer in patients treated with standalone temsirolimus than those treated with standalone. Open the folder that contains the pdf file you want, choose the pdf file, and select ok. Torisel medication page for healthcare professionals to search for scientific information on pfizer medications. Temsirolimus binds to an intracellular protein fkbp12, and the proteindrug complex inhibits the activity of mtor that controls cell division. The approval of temsirolimus for the treatment of metastatic rcc arises from the global study, an international, multicenter, openlabel, threearm phase iii trial that enrolled patients with. Any relevant documentation to support medical necessity package insert, chart or lab notes, letter of medical necessity consult with the payer regarding specific claim and documentation. A kit has been used for the detection of activated caspase 3. The nccn recommends cancer patient participation in clinical trials as the gold standard for treatment.
Torisel temsirolimus injection, 25 mgml, is a clear, colorless to light yellow, nonaqueous, ethanolic, sterile solution. In some cases, health care professionals may use the trade name torisel when referring to the generic drug name temsirolimus. Temsirolimus torisel medical clinical policy bulletins. Highlights of prescribing information these highlights do not include all the information needed to use torisel safely and effectively. Studies with everolimus have also shown that prophylactic use of dexamethasone mouthwash may reduce the incidence of grade 2 or worse stomatitis when used regularly during the first 8 weeks of treatment. Torisel fda prescribing information, side effects and uses. Torisel temsirolimus dosing, indications, interactions.
Torisel temsirolimus injection side effects, images. Cci779 is a potent inhibitor of mtor with ic50 values of 0. Torisel temsirolimus injection side effects, images, uses. Keywords clear cell carcinoma, temsirolimus, mtor, rapamycin, safety. Authorization of 3 months may be granted for members prescribed torisel as primary therapy for disease not suitable for primary surgery in members with suspected or gross cervical. Also find the package insert, announcements, resources, and ways to connect with pfizer medical through a variety of channels. If torisel must be given to patients with mild hepatic impairment, reduce the dose of torisel to 15 mgweek. Insert pdf file content into a powerpoint presentation powerpoint. Patients enrolled in the study had advanced disease and three or more factors indicating a poor prognosis. Sirolimus is extensively metabolized in the intestinal wall and liver and undergoes countertransport from enterocytes of the small.
It is usually given by a doctor or nurse in a doctors office or infusion center. Temsirolimus is also being studied in the treatment of other types of cancer. Temsirolimus inhibits mammalian target of rapamycin mtor kinase signaling by binding to the intracellular protein fkbp12. Torisel temsirolimus injection requires two dilutions prior to.
Renal cell carcinoma a type of kidney cancer that is advanced. Insert pdf content into your presentation either as a picture that shows on your slide, or as a document that you can open during your slide show. Mtt and propidium iodide pi were purchased from sigma aldrich. Torisel, when diluted, contains polysorbate 80, which is known to increase the rate of dehp extraction from pvc. Temsirolimus torisel for mantle cell lymphoma relapsed. Download figure open in new tab download powerpoint. Temsirolimus torisel for kidney cancer chemoexperts. Pfizer seeks to stymie sandoz, accords generic torisel law360. In some cases, health care professionals may use the trade name torisel when referring to the generic drug. Temsirolimus binds to an intracellular protein fkbp12, and the proteindrug complex inhibits the activity of mtor.
Pfizer seeks to stymie sandoz, accords generic torisel. Highlights of prescribing information monitor for symptoms. Cci779 is an ester derivative of rapamycin and has improved pharmaceutical properties. Open your powerpoint presentation on the page you want to insert the pdf within. Temsirolimus is the generic name for the trade name chemotherapy drug torisel. Clinical trials are research studies that involve people. Similar to other molecularly targeted agents, temsirolimus, an inhibitor of mammalian target of rapamycin, has shown promising activity in advanced renal cell. It is administered by intravenous infusion iv, with an anticipated dose regime for mcl of 175mg once weekly for three weeks, followed by 75mg once. The clinical trials on this list are studying temsirolimus. Torisel temsirolimus pfizer medical information us. The clinical benefit of temsirolimus for poorrisk, advanced rcc patients was demonstrated in a phase iii study comparing temsirolimus with interferon alpha ifnalpha or combined temsirolimus plus ifnalpha as firstline treatment of advanced rcc, showed that treatment with temsirolimus alone significantly increased median overall survival in. Torisel should be used with caution in persons with known hypersensitivity to temsirolimus or its metabolites including sirolimus, polysorbate 80, or to any other component including the excipients of torisel. Oct 25, 2019 renal cell carcinoma treatment regimens.
Torisel is indicated for the treatment of advanced renal cell carcinoma. Listing a study does not mean it has been evaluated by the u. Torisel temsirolimus injection should be diluted only with the supplied diluent for torisel. Temsirolimus temsirolimus injection, 25 mgml, is a clear, colorless to light yellow, nonaqueous, ethanolic, sterile solution. Mar 16, 2010 sirolimus or everolimus or temsirolimus and vorinostat in advanced cancer the safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Torisel temsirolimus injection requires two dilutions prior to intravenous infusion. Insert pdf file content into a powerpoint presentation. What are the possible side effects of temsirolimus torisel. Torisel temsirolimus torisel reimbursement support program. Targeting survivin inhibits renal cell carcinoma progression and. Food and drug administration fda in late may 2007, and was also approved by the european medicines agency emea on november 2007. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your. Hypersensitivityinfusion reactions, including flushing, chest pain, dyspnea, hypotension, apnea, loss of consciousness, hypersensitivity, and anaphylaxis. Temsirolimus is the 2,2bis hydroxymethyl propionic acid ester of. Jan 22, 2020 temsirolimus metabolized by hydrolysis to sirolimus, the principal active metabolite. Apr 05, 2018 temsirolimus exhibits a biexponential decline in whole blood concentrations and the mean halflives of temsirolimus and sirolimus were 17. Go to insert and select object to open the insert object dialog box.
In the insert object box, select create from file, and then enter the pdf file location. Sodium bicarbonate solutions or oral antifungal agents do not appear to be effective for. Temsirolimus cancer information cancer research uk. Because many drugs are excreted in human milk, and because of the potential for adverse reactions in nursing infants from temsirolimus, a decision should be made whether to. Sirolimus or everolimus or temsirolimus and vorinostat in advanced cancer the safety and scientific validity of this study is the responsibility of the study sponsor and.
Temsirolimus is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Nov 09, 2018 temsirolimus is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Temsirolimus codenamed cci779 is an intravenous drug for the treatment of renal cell carcinoma rcc, developed by wyeth pharmaceuticals and approved by the u. Temsirolimus binds to and inhibits the mammalian target of rapamycin mtor, resulting in decreased expression of mrnas necessary for cell. Food and drug administration fda in may 2007 for the treatment of. Temsirolimus is supplied as a kit consisting of two vials. Temsirolimus torisel is an inhibitor of mammalian target of rapamycin mtor. Temsirolimus binds to an intracellular protein fkbp. Temsirolimus torisel is an intravenous chemotherapeutic agent in the. Temsirolimus metabolized by hydrolysis to sirolimus, the principal active metabolite.
1224 548 1578 883 885 1206 1625 987 691 687 836 504 541 1146 66 111 610 78 1155 282 725 1546 1 1278 1187 651 1460 465 1040 819 390 1451 550 1273 1269 898